Selection from HEOR Bibliography
| Search criteria | ||||
| South Korea |
||||
| Effectiveness and safety of empagliflozin in routine care in Europe and East Asia: results from the empagliflozin comparative effectiveness and safety (EMPRISE) study | ||||
| A. Karasik1 , S. Lanzinger2 , E. Chia-Hui Tan3 , D. Yabe4 , D. Jung Kim5 , W. H-H Sheu6 , C. MelzerCohen1 , R.W. Holl2 , K. Ha5 , T. Nyström7 , L. Niskanen8 , M. Linnemann Jensen9 , M.H. Kyaw10, J. Núñez11, EMPRISE EU and East Asia Study Group; | ||||
| Maccabi Research & Innovation Center, Tel Aviv University, Tel Aviv, Israel, 2 Inst. for Epidemiology & Medical Biometry, Uni. of Ulm, Ulm, Germany, 3National Research Inst. of Chinese Medicine, Taipei, Taiwan, 4Dept. of Diabetes and Endocrinology, Gifu University Graduate School of Medicine, Gifu, Japan, 5Dept. of Endocrinology & Metabolism, Ajou Uni. School of Medicine, Suwon, Republic of Korea, 6Taipei Veterans General Hospital, Taipei, Taiwan, 7Dept. of Clinical Science & Education, Södersjukhuset, Karolinska Institutet, Solna, Sweden, 8Department of Medicine, Päijät-Häme Central Hospital, Lahti, Finland, 9 IQVIA, Copenhagen, Denmark, 10Boehringer Ingelheim Pharmaceutical Inc., Ridgefield, USA, 11Dept. of Cardiology, Hospital ClÃnico Universitario de Valencia, Valencia, Spain | ||||
| https://doi.org/10.2337/DB21-127-LB Virtual EASD 2021, 57 Annual Meeting, 27 September - 10 October 2021 |
||||
| , Abstract | ||||
| , Finland, Germany, Israel, Japan, South Korea, Spain, Sweden, Taiwan | ||||
| Abstract: https://easddistribute.m-anage.com/from.storage?image=gOIMdpw6-DbPpKIQZ5HFcJGqJ2quHgbqFewkkUQkLblXdwzJ9kfmAYikI6R6NFu_GLAQJwEZKsC1PXU8ndyryA2 | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease, Diabetes | 2021 | English | , Database Study, Methodology, Population Based Study | |
| Cardiovascular Effectiveness of Empagliflozin Compared to DPP-4i in Routine Care in East Asia: Results from the EMPRISE study | ||||
| Dae Jung Kim, Wayne H.-H. Sheu, Wook-Jin Chung, Daisuke Yabe, Kyoung Hwa Ha, Elise Chia-Hui Tan, Yusuke Taneda, Vanessa Lei, Laura Saarelainen, Anouk Deruaz-Luyet, Moe H. Kyaw, Yutaka Seino, EMPRISE East Asia Study Group, Boehringer Ingelheim International GmbH, Ingelheim, Germany, StatFinn - EPID Research an IQVIA Company, Espoo, Finland | ||||
| 1 Ajou University, Suwon, South Korea; 2 Taichung Veterans General Hospital, Taichung, Taiwan; 3 Gachon University Gil Medical Center, Incheon, South Korea; 4 Kansai Electric Power Medical Research Institute, Kobe, Japan; 5 Gifu University Graduate School of Medicine, Gifu, Japan; 6 National Research Institute of Chinese Medicine, Taipei, Taiwan; 7 Nippon Boehringer Ingelheim Co. Ltd., Tokyo, Japan; 8 Boehringer Ingelheim Taiwan Ltd., Taipei, Taiwan; 9 IQVIA, Espoo, Finland; 10 Boehringer Ingelheim International GmbH, Ingelheim, Germany; 11 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA; 12 Kansai Electric Power Hospital, Osaka, Japan | ||||
| J Am Coll Cardiol. 2021 May, 77 (18_Supplement_1) 542. https://doi.org/10.1016/S0735-1097(21)01901-X |
||||
| , Abstract, Presentation | ||||
| , Japan, South Korea, Taiwan | ||||
| Abstract: https://www.jacc.org/doi/epdf/10.1016/S0735-1097%2821%2901901-X | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease, Diabetes | 2021 | English | , Database Study, Methodology, Observational study | |
| Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study | ||||
| Yutaka Seino*, Dae Jung Kim, Daisuke Yabe, Elise Chia-Hui Tan, Wook-Jin Chung, Kyoung Hwa Ha, Masaomi Nangaku, Koichi Node, Riho Klement**, Atsutaka Yasui, Wei-Yu, Sunwoo Lee, Moe H Kyaw, Anouk Deruaz-Luyet, Kimberly G Brodovicz,Wayne H-H Sheu, on behalf of the EMPRISE East Asia study group | ||||
| * Kansai Electric Power Medical Research Institute, Kobe, Japan and Kansai Electric Power Hospital, Osaka, Japan **EPID Research an IQVIA company, Tartu, Estonia | ||||
| Endocrinology, Diabetes and Metabolism 2020;00:e00183 |
||||
| , Article | ||||
| , Japan, South Korea, Taiwan | ||||
| Abstract: https://onlinelibrary.wiley.com/doi/full/10.1002/edm2.183 | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease, Diabetes | 2020 | English | , Epidemiological study, Retrospective database analysis | |
| Cross-sectional study estimating the psychosocial impact of genital warts and other anogenital diseases in South Korea | ||||
| Lee TS1, Kothari-Talwar S2, Singhal PK2, Yee K3, Kulkarni A2, Lara N4, Roset M4, Giuliano AR5, Garland SM6, Ju W7 | ||||
| 1 Department of Obstetrics and Gynecology, SMG-SNU Boramae Medical Center, Seoul, South Korea 2 Merck and Co Inc, Kenilworth, NJ, US 3 Cubist Pharmaceuticals Inc, Lexington, MA, US 4 IQVIA, Barcelona, Spain 5 Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, US 6 Microbiology and Infectious Diseases Department, The Royal Women's Hospital, Parkville, Victoria, Australia 7 School of Medicine, Ewha Womans University, Seoul, South Korea | ||||
| BMJ Open. 2019 Mar 20;9(3):e025035 |
||||
| , Article | ||||
| , South Korea | ||||
| Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30898815 | ||||
| Condition | Year | Language | Analysis type | |
| , Infectious disease | 2019 | English | , Burden of illness, Clinical setting: Primary care, clinical setting: Secondary care | |
| Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia | ||||
| Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3 | ||||
| 1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA | ||||
| , China, France, Germany, Italy, Japan, South Korea, Spain, UK | ||||
| Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e21085 | ||||
| Condition | Year | Language | Analysis type | |
| 2018 | English | |||
| Patterns of care and of biomolecular characterization of Right, Transverse, and Left Colorectal Cancer from real-life evidence in Asia Pacific and European countries | ||||
| Ettore M1, Mpima S2, Guglielmetti F1, Nasuti P2 | ||||
| 1IQVIA , Milan, Italy 2IQVIA , London, UK | ||||
| ESMO 2018 |
||||
| , Poster | ||||
| , China, France, Germany, Italy, Japan, South Korea, Spain, UK | ||||
| Abstract: ESMO 2018 Congress | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2018 | English | ||
| Patterns of Therapy in Regional Lymph Node Positive Prostate Cancer in Europe and Asia: An International Analysis | ||||
| Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R, Payne H 1 | ||||
| 1 University College Hospital, London, UK 2 IQVIA , London, UK | ||||
| ESMO 2018 |
||||
| , Poster | ||||
| , China, France, Germany, Italy, Japan, South Korea, Spain, UK | ||||
| Abstract: ESMO 2018 Congress | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2018 | English | ||
| Initial Management of localised prostate cancer in the Elderly: An International Data Review | ||||
| Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R1, Payne H1 | ||||
| 1 University College Hospital, London, UK 2 IQVIA , London, UK | ||||
| SIOG 2018 |
||||
| , Poster | ||||
| , China, France, Germany, Italy, Japan, South Korea, Spain, UK | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2018 | English | ||
| Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia | ||||
| Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3 | ||||
| 1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA | ||||
| JCO ( ASCO 2018) |
||||
| , Abstract | ||||
| , Asia Pacific, China, Europe, France, Germany, Italy, Japan, South Korea, Spain, UK | ||||
| Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e21085 | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2018 | English | ||
| The cost-effectiveness of travoprost preserved with polyquad® in newly treated open-angle glaucoma patients in 7 Asian countries. | ||||
| Gerlier L1, Lamotte M1, Caputo J2, Tan R3 | ||||
| 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore | ||||
| 5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan |
||||
| , Abstract, Poster | ||||
| , India, Malaysia, Singapore, South Korea, Thailand | ||||
| Condition | Year | Language | Analysis type | |
| , Ophthalmology | 2012 | English | , Cost effectiveness | |
| Medical resource use and associated costs in open-angle glaucoma in 10 Asia-pacific countries. | ||||
| Gerlier L1, Lamotte M1, Caputo J2, Tan R3 | ||||
| 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore | ||||
| 5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan |
||||
| , Abstract, Poster | ||||
| , Australia, China, Hong Kong, India, Malaysia, New Zealand, Singapore, South Korea, Taiwan, Thailand | ||||
| Condition | Year | Language | Analysis type | |
| , Ophthalmology | 2012 | English | , Burden of illness | |
| Modelling the cost-effectiveness of acarbose in preventing type 2 diabetes in a South Korean setting | ||||
| JongMann K1, Clegg JP2, Chang K1, JuYeol P1, Wittrup-Jensen KU3, Palmer AJ2, Roze S2, Valentine WJ2 | ||||
| 1Bayer, Seoul, South Korea, 2IMS Health, Allschwil, Switzerland, 3Bayer Schering Pharma AG, Berlin, Germany, | ||||
| ISPOR 3rd Asia-Pacific Conference |
||||
| , Oral presentation | ||||
| , South Korea | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2008 | English | , Cost effectiveness | |